U.S. FDA Approves New Protocol for Study on Bayer ' s Essure Birth Control Device U.S. FDA Approves New Protocol for Study on Bayer ' s Essure Birth Control Device

The U.S. Food and Drug Administration on Thursday approved a new protocol for a post-marketing study of Bayer AG ' s Essure birth-control device, as the regulator seeks more information on the device ' s safety.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Alert Source Type: news